EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape

Stephanie Gehrs, Zuguang Gu, Joschka Hey, Dieter Weichenhan iD, Niklas Buckwalter, Moritz Jakab, Agnes Hotz-Wagenblatt, Kersten Breuer, Maria Llamazares Prada, Daniel Hübschmann, Katharina Schlereth, Christoph Plass iD und 1 weitere

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Stephanie Gehrs und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: DNA Methylation, DNA (Cytosine-5-)-Methyltransferases, Endothelial Cells, Enhancer Elements, Genetic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, European Research Council, German Center for Lung Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA methylation plays a fundamental role in regulating transcription during development and differentiation. However, its functional role in the regulation of endothelial cell (EC) transcription during state transition, meaning the switch from an angiogenic to a quiescent cell state, has not been systematically studied. Here, we report the longitudinal changes of the DNA methylome over the lifetime of the murine pulmonary vasculature. We identified prominent alterations in hyper- and hypomethylation during the transition from angiogenic to quiescent ECs. Once a quiescent state was established, DNA methylation marks remained stable throughout EC aging. These longitudinal differentially methylated regions correlated with endothelial gene expression and highlighted the recruitment of de novo DNA methyltransferase 3a (DNMT3A), evidenced by its motif enrichment at transcriptional start sites of genes with methylation-dependent expression patterns. Loss-of-function studies in mice revealed that the absence of DNMT3A-dependent DNA methylation led to the loss of active enhancers, resulting in mild transcriptional changes, likely due to loss of active enhancer integrity. These results underline the importance of DNA methylation as a key epigenetic mechanism of EC function during state transition. Furthermore, we show that DNMT3A-dependent DNA methylation appears to be involved in establishing the histone landscape required for accurate transcriptome regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationDNA (Cytosine-5-)-MethyltransferasesEndothelial CellsEnhancer Elements, GeneticDNA Methyltransferase 3AAnimalsMiceEpigenesis, GeneticNeovascularization, PhysiologicGene Expression RegulationHumans

Substanzen

DNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDnmt3a protein, mouseDNMT3A protein, human

Autor:innen und Institutionen

  • Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Department of Vascular Biology and Tumor Angiogenesis (CBTM), Medical Faculty Mannheim, Heidelberg University, 69120 Heidelberg, Germany.
  • Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.
  • Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Core Facility Omics IT and Data Management (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

ORCID-Profile: Dieter Weichenhan, Christoph Plass, Hellmut Augustin

Förderung

  • Deutsche Forschungsgemeinschaft
  • European Research Council
  • German Center for Lung Disease
  • German-Israeli Helmholtz International Research School Cancer-TRAX
  • DKFZ Heidelberg
  • German–Israeli Helmholtz International Research School Cancer-TRAX

Zitieren

APA

Gehrs, S., Gu, Z., Hey, J., Weichenhan, D., Buckwalter, N., Jakab, M., Hotz-Wagenblatt, A., Breuer, K., Prada, M. L., Hübschmann, D., Schlereth, K., Plass, C., & Augustin, H. (2025). DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf435

Vancouver

Gehrs S, Gu Z, Hey J, Weichenhan D, Buckwalter N, Jakab M, et al. DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf435

BibTeX
@article{Gehrs2025,
  author = {Gehrs, Stephanie and Gu, Zuguang and Hey, Joschka and Weichenhan, Dieter and Buckwalter, Niklas and Jakab, Moritz and Hotz-Wagenblatt, Agnes and Breuer, Kersten and Prada, Maria Llamazares and Hübschmann, Daniel and Schlereth, Katharina and Plass, Christoph and Augustin, Hellmut},
  title = {DNMT3A-dependent DNA methylation shapes the endothelial enhancer landscape},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf435}
}
Kostenlos starten →